Prostatic Neoplasm: Clinical Trials

7 trials for Prostatic Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7
Phase 22Completed 2

Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EBRT + Lu-PSMA for N1M0 Prostate Cancer
177Lu-PSMA-617, EBRT - Prostatic Neoplasm
Phase 1CompletedThe Netherlands Cancer Institute142021-12-202025-12-10
Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit
Gallium-68 PSMA-11 prepared using PSMA-11 Sterile Cold Kit - Prostatic Neoplasm
Phase 1CompletedCliniques universitaires Saint-Luc- Université Catholique de Louvain32019-01-242020-10-26
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
18F-DCFPyL, Tumor Irradiation, Prostate + tumor irradiation - Prostate Cancer, Prostatic Neoplasm
Phase 1CompletedNational Cancer Institute (NCI)172018-07-052025-10-08
Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer
radioimmuniguided intenstiy modulated radiotherapy - Prostatic Neoplasm
Phase 1 / Phase 2CompletedMayo Clinic722006-10-012011-02-25
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms
PF00562271 - Head and Neck Neoplasm, Prostatic Neoplasm
Phase 1CompletedVerastem, Inc.992005-12-012013-03-21
Preop Conformal Radiotherapy - Prostate
Pre-Operative Conformal Radiotherapy - Prostatic Neoplasm
Phase 1 / Phase 2CompletedUniversity Health Network, Toronto152000-05-012010-08-11
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
7-hydroxystaurosporine (UCN-01) - Breast Cancer, Lymphoma
Phase 1CompletedNational Cancer Institute (NCI)511995-08-012008-03-04

Narrower conditions

Prostatic Neoplasms (7)  ·  Breast Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lymphoma (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Genital Diseases (7)  ·  Genital Diseases, Male (7)  ·  Genital Neoplasms, Male (7)  ·  Male Urogenital Diseases (7)  ·  Neoplasms by Site (7)  ·  Prostatic Diseases (7)  ·  Urogenital Diseases (7)  ·  Urogenital Neoplasms (7)  ·  Neoplasms (6)  ·  Breast Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

18F-JK-PSMA-7 (1)  ·  2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1)  ·  7-hydroxystaurosporine (1)  ·  PF-00562271 (1)  ·  Pluvicto (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Mayo Clinic (1)  ·  The Netherlands Cancer Institute (1)  ·  University Health Network, Toronto (1)  ·  Verastem, Inc. (1)

Countries

United States (4)  ·  Canada (2)  ·  Australia (1)  ·  Belgium (1)  ·  Netherlands (1)

Top investigators

Deborah E Citrin, M.D. (1)  ·  Padraig Warde, MD (1)  ·  Wouter V Vogel, MD, PhD (1)

Results publications

PMID 36959540, PMID 38428681